Joinn Laboratories(China)Co.,Ltd. provided earnings guidance for the six months ended 30 June 2024. For the period, the company expects that the revenue for the First Half of 2024 will be approximately RMB 719,495,800 to RMB 973,435,500, and will decrease approximately RMB 38,641,700 to RMB 292,581,500 as compared with the data for the corresponding period of last year, representing a period-on-period decrease of approximately 3.8% to 28.9%. It is expected that the net profit attributable to the shareholders of the Company for the First Half of 2024 will be approximately RMB-184,356,300 to RMB-136,263,300, and will record a loss as compared with the data for the corresponding period of last year.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.95 CNY | +0.72% |
|
+7.72% | -41.16% |
11/07 | Hong Kong Stocks Rally on Chinese Regulator's Fresh Curbs on Short-Selling | MT |
11/07 | JOINN Laboratories (China) Flags Losses in H1; Shares Rise 10% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.16% | 1.31B | |
+24.33% | 46.56B | |
+45.38% | 41.67B | |
-0.60% | 41.16B | |
+33.19% | 32.4B | |
+20.61% | 28.18B | |
-6.35% | 28.1B | |
+49.45% | 14.52B | |
+47.43% | 13.74B | |
+2.09% | 12.17B |
- Stock Market
- Equities
- 603127 Stock
- News Joinn Laboratories(China)Co.,Ltd.
- Joinn Laboratories(China)Co.,Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2024